Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Contralaterally Controlled FES Combined With Brain Stimulation for Severe Upper Limb Hemiplegia

NCT03870672 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT03870672
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03870672 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Contralaterally Controlled FES Combined With Brain Stimulation for Severe Upper Limb Hemiplegia
Lead sponsor
The Cleveland Clinic
Phase
Not applicable
Overall status
Active, not recruiting
Start date
May 14, 2019
Completion date
December 31, 2026
Enrollment
72 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebrovascular accident (cva), hemiparesis, hemiplegia, stroke